Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Profound Medical (PROF : NSDQ)

• Company Description    Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada. Number of Employees: 162

• Price / Volume Information    Yesterday's Closing Price: $6.83 Daily Weekly Monthly 20 Day Moving Average: 76,298 shares Shares Outstanding: 36.34 (millions) Market Capitalization: $248.19 (millions) Beta: 0.73 52 Week High: $8.95 52 Week Low: $3.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.19% -3.76% 12 Week -12.15% -18.79% Year To Date -13.21% -18.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2400 SKYMARK AVENUE UNIT 6 - MISSISSAUGA,A6 L4W 5K5 CAN ph: 64-7476-1350 fax: 64-7847-3739 skilmer@profoundmedical.com http://www.profoundmedical.com

• General Corporate Information    Officers Arun Menawats - Chief Executive Officer and Director Rashed Dewan - Chief Financial Officer Brian Ellacott - Director Cynthia Lavoie - Director Murielle Lortie - Director Peer Information Profound Medical (GSAC) Profound Medical (CASIF) Profound Medical (ALCD.) Profound Medical (OMNN) Profound Medical (CGPI.) Profound Medical (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 74319B502 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 36.34 Most Recent Split Date: (:1) Beta: 0.73 Market Capitalization: $248.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.21 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.86 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.18 Price/Cash Flow: - Price / Sales: 13.19 EPS Growth vs. Year Ago Period: 47.22% vs. Previous Quarter: 29.63% Sales Growth vs. Year Ago Period: 103.62% vs. Previous Quarter: -10.71% ROE 03/31/26 - -78.88 12/31/25 - -90.28 09/30/25 - -86.18 ROA 03/31/26 - -64.06 12/31/25 - -73.94 09/30/25 - -70.55 Current Ratio 03/31/26 - 6.56 12/31/25 - 12.52 09/30/25 - 4.18 Quick Ratio 03/31/26 - 5.71 12/31/25 - 11.17 09/30/25 - 3.34 Operating Margin 03/31/26 - -206.76 12/31/25 - -264.45 09/30/25 - -275.16 Net Margin 03/31/26 - -206.76 12/31/25 - -264.45 09/30/25 - -275.16 Pre-Tax Margin 03/31/26 - -205.50 12/31/25 - -262.88 09/30/25 - -275.25 Book Value 03/31/26 - 1.64 12/31/25 - 1.83 09/30/25 - 1.06 Inventory Turnover 03/31/26 - 0.64 12/31/25 - 0.59 09/30/25 - 0.54 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.07 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 6.34 09/30/25 - 0.00

Powered by Zacks Investment Research ©